FGF-19 analogues for the treatment of metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis

被引:0
|
作者
Khalil, Samira Mohamad [1 ]
Souza, Matheus [2 ]
de Oliveira, Fabiana Dolovitsch [3 ]
Buarque de Santana Sato, Emmily Daiane [4 ]
Meine, Gilmara Coelho [5 ]
机构
[1] Univ Buenos Aires, Buenos Aires, DF, Argentina
[2] Univ Fed Rio De Janeiro, Rio De Janeiro, Brazil
[3] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil
[4] Pontificia Univ Catolica Campinas, Campinas, Brazil
[5] Univ Feevale, Novo Hamburgo, Brazil
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-244
引用
收藏
页码:S618 / S619
页数:2
相关论文
共 50 条
  • [31] The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
    Untaaveesup, Suvijak
    Kantagowit, Piyawat
    Ungprasert, Patompong
    Kitlertbanchong, Nitchanan
    Vajiraviroj, Tanyatorn
    Sutithavinkul, Tanpichcha
    Techataweewan, Gynna
    Eiumtrakul, Wongsathorn
    Threethrong, Rinrada
    Chaemsupaphan, Thanaboon
    Pratchyapruit, Walaiorn
    Sriphrapradang, Chutintorn
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [32] Association between metabolic dysfunction-associated steatotic liver disease and risk of urolithiasis: an updated systematic review and meta-analysis
    Mantovani, Alessandro
    Morandin, Riccardo
    Fiorio, Veronica
    Lando, Maria Giovanna
    Petta, Salvatore
    Ferraro, Pietro Manuel
    Targher, Giovanni
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (06) : 1745 - 1755
  • [33] The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis
    Lv, Qiong
    Zhao, Huashan
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [34] The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis
    Agustanti, Nenny
    Soetedjo, Nanny Natalia Mulyani
    Damara, Fachreza Aryo
    Iryaningrum, Maria Riastuti
    Permana, Hikmat
    Bestari, Muhamad Begawan
    Supriyadi, Rudi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (05)
  • [36] Association between metabolic dysfunction-associated steatotic liver disease and risk of thyroid cancer: a systematic review and meta-analysis
    Chen, Jiahao
    Gao, Yingzheng
    Fu, Tao
    Gu, Yi
    Du, Weidong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (02) : 119 - 128
  • [37] The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
    Li, Xiaoyan
    He, Jie
    Sun, Qiuhua
    CLINICAL NUTRITION, 2024, 43 (09) : 2005 - 2016
  • [38] Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
    Malik, Adnan
    Malik, Muhammad
    Qureshi, Shahbaz
    CANADIAN LIVER JOURNAL, 2024, 7 (01): : 40 - 53
  • [39] Efficacy and safety of the FGF19 analog aldafermin for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis
    Ali, Mohammad Haris
    Rehman, Obaid Ur
    Talha, Muhammad
    Fatima, Eeshal
    Fatima, Laveeza
    Zain, Ahmad
    Haisbuzzaman, Md Al
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (12): : 7072 - 7081
  • [40] BARIATRIC SURGERY IMPROVES MRI-DETERMINED HEPATIC PROTON DENSITY FAT FRACTION AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS IN PATIENTS WITH OBESITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cho, Yuri
    Shin, Hyunjae Shin
    Kim, Bo Hyun
    Hwang, Juchul Hwang
    Hwang, Hyeyoung
    Jun, Dae Won
    Choi, Mi Young
    HEPATOLOGY, 2024, 80 : S1948 - S1948